Liraglutide vs Semaglutide: Comparing GLP-1s | Eden

When it comes to managing obesity and type 2 diabetes, GLP-1 receptor agonists like liraglutide (Saxenda®, Victoza®) and semaglutide (Wegovy®, Ozempic®; only approved for T-2 diabetes management) have become commonly used treatment options. 

Both medications mimic the GLP-1 hormone to regulate blood sugar and appetite but differ in dosing, efficacy, and FDA approvals. Eden explains these differences between liraglutide and semaglutide forms so you can have an informed conversation with a healthcare provider about your treatment options.

‍

What Are GLP-1 Agonists?

GLP-1 (glucagon-like peptide-1) agonists are injectable medications that can produce the following effects:

• Slow digestion to promote fullness
• Reduce appetite and cravings
• Improve insulin sensitivity
• Lower blood sugar levels

There are many different types of GLP-1 agonists, and they’re just one part of your metabolic health treatment plan if you have type 2 diabetes or obesity. Your healthcare provider can help you decide if they’re right for you. 

While initially designed for type 2 diabetes, drugs like liraglutide and semaglutide are now FDA-approved for chronic weight management.

Please note that compounded medications are prepared by state-licensed compounding pharmacies. These formulations are not reviewed by the FDA for safety, quality or efficacy. Individual results may vary. Consult a licensed healthcare provider to determine if treatment is right for you. 
‍

Liraglutide Overview

Liraglutide is a GLP-1 receptor agonist that belongs to the incretin mimetics group. It is FDA-approved in different formulations for managing type 2 diabetes (Victoza®) and weight management (Saxenda®). 

Liraglutide influences insulin release and slows gastric emptying, which may play a role in regulating blood sugar and appetite. 

Brand Names: Saxenda® (weight loss), Victoza® (diabetes) 

FDA Approvals:

• Type 2 diabetes (Victoza®)
• Obesity (Saxenda®)

How It Works

• Dosing: Daily injections
• Mechanism: Activates GLP-1 receptors in the brain and pancreas to suppress appetite and stabilize blood sugar.
• Efficacy:
  
  • Weight Loss: Patients can lose 5-10% of body weight over 56 weeks.
  • Diabetes: Reduces HbA1c by 1.0–1.5%.

Who Should Use It?

• Adults with a BMI ≥30 or ≥27 + weight-related conditions (Saxenda®).
• Type 2 diabetes patients needing glycemic control (Victoza®).
  ‍

Semaglutide Overview

Semaglutide is a GLP-1 receptor agonist and incretin mimetic that shares structural similarities with the natural GLP-1 hormone. It is FDA-approved in different formulations for managing type 2 diabetes (Ozempic®) and weight management (Wegovy®).

 Semaglutide influences insulin secretion in response to glucose and plays a role in regulating blood sugar and appetite.

Brand Names: Wegovy® (weight loss), Ozempic® (diabetes) 

FDA Approvals:

• Type 2 diabetes (Ozempic®)
• Obesity (Wegovy®)

How It Works

• Dosing: Weekly injections (Wegovy®, Ozempic®) or daily oral tablets (Rybelsus®).
• Mechanism: A longer-acting GLP-1 agonist with stronger receptor activation.
• Efficacy:
  
  • Weight Management: When combined with diet and exercise, some patietns may experience weight management benefits
  • Diabetes: Reduces HbA1c by 1.5–2.0%.

Who Should Use It?

• Adults with obesity (BMI ≥30 or ≥27 + comorbidities) for Wegovy®.
• Type 2 diabetes patients requiring aggressive blood sugar management (Ozempic®).

Liraglutide vs Semaglutide: Side-by-Side Comparison

‍

‍

Differences to Consider Between Liraglutide vs Semaglutide

1. Efficacy for Weight Loss

• Studies suggest that semaglutide (Wegovy®) and liraglutide (Saxenda®) may have different effects on weight management when combined with diet and exercise.
  
  • Clinical studies of FDA-approved medications have shown varying results when combined with diet and exercise. 
• Why? Semaglutide has a longer half-life than liraglutide, which may contribute to its effects on appetite regulation and weight management.

2. Dosing Convenience

• Some patients may find different dosing schedules work better for their lifestyle. 
• Liraglutide requires daily administration, which may affect adherence.

3. Diabetes Management

• Both drugs lower blood sugar levels in type 2 diabetes, and some studies suggest that semaglutide (Ozempic®) may lead to more significant HbA1c reductions than liraglutide.
• Semaglutide also reduces cardiovascular risk in diabetes patients.

4. Side Effect Profile

• Gastrointestinal issues (nausea, diarrhea) are common with both drugs but are more intense with semaglutide.
• Symptoms may subside after 4–8 weeks.

5. Cost and Insurance Coverage

• Liraglutide: Slightly cheaper, but still costly without insurance ($469–$1,500/month for non-compounded versions).
• Semaglutide: Higher price ($997–$1,350/month for non-compounded versions), but manufacturer coupons may offset costs.
• Many insurers cover these drugs for diabetes but restrict access for weight loss.
  ‍

Who Is a Better Candidate for Liraglutide?

• Patients who prefer daily dosing to track effects closely.
• Those with mild obesity (BMI 27–30) and no urgent need for rapid weight loss.
• Individuals sensitive to semaglutide’s side effects.
  ‍

Who Is a Better Candidate for Semaglutide?

• Patients needing significant weight loss (BMI ≥30) or improved glycemic control.
• Those prioritizing convenience with weekly injections.
• Individuals without severe GI sensitivities.

‍

Safety and Long-Term Use

Both drugs are considered safe for long-term use but come with warnings:

• Thyroid C-Cell Tumor Risk: Both carry a black-box warning for thyroid cancer (avoid if personal/family history).
• Pancreatitis: Rare but serious; discontinue if severe abdominal pain occurs.
• Pregnancy: Not recommended—stop treatment if planning pregnancy.

‍

Cost-Saving Tips for GLP-1 Agonists

Use Manufacturer Savings Programs:

• Novo Nordisk (maker of both drugs) offers coupons reducing Saxenda®/Wegovy® costs by up to $800/month.
• Eligibility: Commercial insurance holders (excludes Medicare/Medicaid).

Compare Pharmacies:

• Retailers like Costco or Sam’s Club often price medications 10–15% lower than CVS/Walgreens.

Prioritize Insurance Coverage:

• For diabetes: Both drugs are widely covered.
• For obesity: Submit a letter of medical necessity from your doctor highlighting comorbidities.

Consider Alternatives:

• Oral semaglutide (Rybelsus®) or older drugs like phentermine may be cheaper.

‍

How Eden Can Help You Access Treatment

Eden simplifies your path to weight loss:

• Price Transparency: Eden’s “Same Price at Every Dose” guarantee offers consistent pricing for every dose and medication.
• Telehealth Consultations: Eden connects you with licensed providers for a telehealth consultation to discuss treatment options.
• Savings Information: Take advantage of Eden's competitive pricing and learn about available coupons or patient assistance programs.

Explore  weight management options through Eden for information about GLP-medications, FAQs, and patient experiences. Final Thoughts

Choosing between liraglutide and semaglutide hinges on your health profile, weight loss goals, and lifestyle. Both medications have differnt dosing schedules and may have varying effects when combined with diet and exercise.Eden can connect you with licensed healthcare providers who can help determine if treatment may be right for you. 

Ready to take the next step? Start your assessment by completing our health questionnaire and Eden will  connect you with a licensed healthcare provider

Eden does not practice medicine or prescribe medications. Eden can connect you with licensed healthcare providers who may prescribe medications post-assessment.

‍